Central Virginia

A WMRA podcast alludes to UVA's role in the biotechnology industry in Central Virginia.

Insulin delivery technology developed at UVA and commercialized by TypeZero Technologies, Inc. received initial support from UVA's Licensing and Ventures Group (LVG).

The UVA Licensing & Ventures Group (LVG) has invested in three Charlottesville-based ventures that grew out of University research. TypeZero Technologies Inc., TearSolutions Inc., and Mission Secure Inc.

Mission Secure Inc. recently announced the closing of an $8 million Series A financing round led by Energy Innovation Capital and Chevron Technology Ventures.

Women engineers at UVA host high school women each year to promote STEM and engineering as an accessible career path.

Albemarle County, Perrone Robotics, Inc., and Jaunt, Inc. announced a partnership that will develop, test, and operate an autonomous transit shuttle service pilot beginning in March of 2019.

Plans are underway to create ease of connection between UVA's Research Park, CHO, and the Hollymead Town Center to benefit Virginia visitors and businesses.

The UVA Research Park is a 562-acre park that provides state-of-the-art facilities to develop the creation and enhancement of research and business collaboration between the University and the public and private sectors — all for the economic and s

As an applied research center, CCAM brings together academia, government, and industry to create the ideal environment for members to conduct meaningful, collaborative research.

Industry clusters are groups of firms that gain a competitive advantage by co-locating in a geographic region and sharing assets, networks, knowledge, workforce training, etc. The Office of Economic Development partners with allies to help support…

UVA was named a National Science Foundation I-Corps Site—one of 89 such sites at universities in the nation—to help entrepreneurs consider customer feedback in developing ideas that are relevant to society and exhibit applications for commerciali

UVA supports regional commercialization, investing directly in companies that take the University’s research and intellectual property to market and increasing the pace for new medical products that improve the health of Virginians and beyond.